New

Esketamine Nasal Spray NDA Submitted to FDA for Treatment-Resistant Depression

The NDA includes five Phase 3 studies in patients with treatment-resistant depression: 3 short-term studies, 1 withdrawal maintenance of effect study, and 1 long-term safety study.

New

FDA Rejects ADHD Drug NDA Citing Need for More Data

The FDA stated that the dasotraline NDA cannot be approved in its current form and is requiring additional data to further assess the efficacy and tolerability of the drug.

New

Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom

Medical students are choosing to forego lectures to use the time studying for the Step 1 exam instead.

New

New White House Rule Could Create Serious Health Concerns for Immigrants

The latest proposed change to immigration policy from the White House may have serious effects on health care.

New

Child Maltreatment Associated With Poor Psychological Health Outcomes in Adulthood

These findings suggest that child maltreatment affects physical health in adulthood.